Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

103.20 UNCHANGED
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,650,517
Open 102.70
Bid (Size) 102.80 (1)
Ask (Size) 103.25 (1)
Prev. Close 103.20
Today's Range 102.70 - 103.39
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
7 Analysts Have This To Say About Abbott Laboratories
Via Benzinga

Performance

YTD
-6.05%
-6.05%
1 Month
+0.32%
+0.32%
3 Month
-7.87%
-7.87%
6 Month
-6.05%
-6.05%
1 Year
-3.75%
-3.75%

More News

Read More
3 MedTech Stocks to Buy for Healthy Gains
Via InvestorPlace
Market Whales and Their Recent Bets on ABT Options
Via Benzinga
Stocks Going Ex Dividend In July 2024
Via Talk Markets
Abbott Laboratories's Options: A Look at What the Big Money is Thinking
Via Benzinga
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
Via InvestorPlace
Top Analyst Reports For Abbott, BP & Gilead
Via Talk Markets
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist in June
Via The Motley Fool
2 Magnificent Dividend Growth Stocks to Buy Now
Via The Motley Fool
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Via The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
Via InvestorPlace
Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches
Via InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
Via Benzinga
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.